Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma.

Abstract excerpt

The fight against rare cancers faces myriad challenges, including missed or wrong diagnoses, lack of information and diagnostic tools, too few samples and too little funding. Yet many advances in cancer biology, such as the realization that there are tumour suppressor genes, have come from studying well-defined, albeit rare, cancers. Fibrolamellar hepatocellular carcinoma (FLC), a typically lethal liver cancer,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Phenotype
• Share to Carcinoma, Hepatocellular
• Share to Liver Neoplasms